Pasithea Therapeutics appoints Kartik Krishnan as Chief Medical Officer, effective May 1, 2026

Pasithea Therapeutics Corp.

Dr. Krishnan appointed CMO effective May 1; will lead PAS-004 clinical strategy for NF1-associated neurofibromas.
Over 20 years of experience; previously CMO at Arcus Biosciences, contributed to cobimetinib approval for melanoma.
Employment agreement: $500k base salary, 40% bonus eligibility, and options for 1.13M shares at $0.841 exercise price.
CEO Tiago Reis Marques granted options for 1.76M shares; other execs/employees received 1.24M shares in aggregate.
Non-employee directors each receive options for 152,783 shares, vesting over one year.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kartik Krishnan

Chief Medical Officer

KTTA · Pasithea Therapeutics Corp.

Effective: 2026-05-01
Filed: May 4, 2026, 7:59 PM ET

On May 4, 2026, Pasithea Therapeutics Corp. (the “Company”) announced the appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer of the Company, effective May 1, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kartik Krishnan was appointed as Chief Medical Officer at Pasithea Therapeutics Corp..

Action: appointed
Role: Chief Medical Officer

Exact text from the filing

On May 4, 2026, Pasithea Therapeutics Corp. (the “Company”) announced the appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer of the Company, effective May 1, 2026.

View on SEC.gov

Pasithea Therapeutics Corp. filing history →

Source: SEC EDGAR

accession 0001213900-26-051681

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.